Instadose Price To Sales Ratio vs Average Payables Analysis
| INSD Stock | USD 0 0.00 0.00% |
Instadose Pharma financial indicator trend analysis is infinitely more than just investigating Instadose Pharma Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Instadose Pharma Corp is a good investment. Please check the relationship between Instadose Pharma Price To Sales Ratio and its Average Payables accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Instadose Pharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
Price To Sales Ratio vs Average Payables
Price To Sales Ratio vs Average Payables Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Instadose Pharma Corp Price To Sales Ratio account and Average Payables. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Instadose Pharma's Price To Sales Ratio and Average Payables is -0.47. Overlapping area represents the amount of variation of Price To Sales Ratio that can explain the historical movement of Average Payables in the same time period over historical financial statements of Instadose Pharma Corp, assuming nothing else is changed. The correlation between historical values of Instadose Pharma's Price To Sales Ratio and Average Payables is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Price To Sales Ratio of Instadose Pharma Corp are associated (or correlated) with its Average Payables. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Average Payables has no effect on the direction of Price To Sales Ratio i.e., Instadose Pharma's Price To Sales Ratio and Average Payables go up and down completely randomly.
Correlation Coefficient | -0.47 |
| Relationship Direction | Negative |
| Relationship Strength | Very Weak |
Price To Sales Ratio
Price to Sales Ratio is figured by comparing Instadose Pharma Corp stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Instadose Pharma sales, a figure that is much harder to manipulate than other Instadose Pharma Corp multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.Average Payables
The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.Most indicators from Instadose Pharma's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Instadose Pharma Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Instadose Pharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. At present, Instadose Pharma's Enterprise Value is projected to increase significantly based on the last few years of reporting.
Instadose Pharma fundamental ratios Correlations
Click cells to compare fundamentals
Instadose Pharma Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Instadose Pharma fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Current Liabilities | 33.5K | 56.7K | 82.4K | 162.3K | 186.6K | 196.0K | |
| Total Stockholder Equity | (33.4K) | (56.7K) | (82.4K) | (162.3K) | (146.1K) | (138.8K) | |
| Net Tangible Assets | (33.4K) | (56.7K) | (82.4K) | (162.3K) | (146.1K) | (138.8K) | |
| Retained Earnings | (57.4K) | (80.7K) | (106.4K) | (568.4K) | (511.5K) | (486.0K) | |
| Accounts Payable | 797.0 | 1.0K | 82.4K | 77.6K | 89.2K | 93.7K | |
| Total Liab | 33.5K | 56.7K | 82.4K | 162.3K | 186.6K | 196.0K | |
| Net Invested Capital | (33.4K) | (56.7K) | (82.4K) | (162.3K) | (146.1K) | (138.8K) | |
| Net Working Capital | (33.4K) | (56.7K) | (82.4K) | (162.3K) | (146.1K) | (138.8K) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Instadose Pharma Corp is a strong investment it is important to analyze Instadose Pharma's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Instadose Pharma's future performance. For an informed investment choice regarding Instadose Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Instadose Pharma Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Instadose Pharma. If investors know Instadose will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Instadose Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.01) | Return On Assets (694.06) |
The market value of Instadose Pharma Corp is measured differently than its book value, which is the value of Instadose that is recorded on the company's balance sheet. Investors also form their own opinion of Instadose Pharma's value that differs from its market value or its book value, called intrinsic value, which is Instadose Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Instadose Pharma's market value can be influenced by many factors that don't directly affect Instadose Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Instadose Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Instadose Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Instadose Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.